FDA Drug Application (203975) for ANORO ELLIPTA by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number203975
Product Number001
FormPOWDER;INHALATION
DosageEQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameANORO ELLIPTA
Active IngredientUMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

Active IngredientCount
List of drugs with Active Ingredient UMECLIDINIUM BROMIDE2
List of drugs with Active Ingredient VILANTEROL TRIFENATATE2


Back to FDA Applications sponsored by GLAXOSMITHKLINE